Davide Cintorino

Dr. Davide Cintorino


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
Andrea LauterioAndrea Lauterio
Andrea Lauterio
Umberto CilloUmberto Cillo
Umberto Cillo
MSMarco Spada
Marco Spada
STSilvia Trapani
Silvia Trapani
RCRiccardo De Carlis
Riccardo De Carlis
EAEnzo Andorno
Enzo Andorno

1 June 2020 in Transplantation Proceedings
Verified
Journal Article
Closed access
Duilio PaganoDuilio Pagano
Duilio Pagano
Marco BarbaraMarco Barbara
Marco Barbara
ASAurelio Seidita
Aurelio Seidita
DCDavide Cintorino
Davide Cintorino
FBFabrizio Di Benedetto
Fabrizio Di Benedetto
Salvatore GruttadauriaSalvatore Gruttadauria
Salvatore Gruttadauria

19 December 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
MSMarco Spada
Marco Spada
Roberta AngelicoRoberta Angelico
Roberta Angelico
STSilvia Trapani
Silvia Trapani
LMLucia Masiero
Lucia Masiero
FPFrancesca Puoti
Francesca Puoti
MCMassimo Cardillo
Massimo Cardillo

6 June 2010 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
MPMarta Di Pisa
Marta Di Pisa
ITilaria tarantino
ilaria tarantino
LBLuca Barresi
Luca Barresi
DCDavide Cintorino
Davide Cintorino
MTMario Traina
Mario Traina
We report two cases of severe postsphincterotomy bleeding in an adult and a pediatric patient treated, as first options, with available techniques to induce hemostasis without success. Because of persisting bleeding, an expandable, partially covered, metallic stent was placed into the choledocho to mechanically compress the bleeding site. The bleeding was stopped. In the following days, both patients remained hemodynamically stable with no further episodes of bleeding. We believe that the application of a covered metallic stent in a severe postendoscopic-sphincterotomy bleeding, refractory to injection therapy, should be considered to avoid additional interventions, which carry a higher risk of complications, even in pediatric patients.

1 November 2019 in Transplantation Proceedings
Verified
Journal Article
Closed access
CRCalogero Ricotta
Calogero Ricotta
DCDavide Cintorino
Davide Cintorino
Duilio PaganoDuilio Pagano
Duilio Pagano
PBPasquale Bonsignore
Pasquale Bonsignore
SPSalvatore Piazza
Salvatore Piazza
SGSalvatore Gruttadauria
Salvatore Gruttadauria

27 December 2018 in BMC Surgery
Verified
Journal Article
Open access
PDF file
Duilio PaganoDuilio Pagano
Duilio Pagano
EOElisabetta Oliva
Elisabetta Oliva
SKSimone Khouzam
Simone Khouzam
FTFabio Tuzzolino
Fabio Tuzzolino
DCDavide Cintorino
Davide Cintorino
Salvatore GruttadauriaSalvatore Gruttadauria
Salvatore Gruttadauria
Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this damage and improve outcomes for transplant recipients. The aim of this study is to evaluate the benefits of treating the donor liver with Simvastatin compared with the standard transplant procedure. We propose a prospective, double-blinded, randomized phase 2 study of 2 parallel groups of eligible adult patients. We will compare 3-month, 6-month, and 12-month graft survival after LT, in order to identify a significant relation between the two homogenous groups of LT patients. The two groups only differ by the Simvastatin or placebo administration regimen while following the same procedure, with identical surgical instruments, and medical and nursing skilled staff. To reach these goals, we determined that we needed to recruit 106 patients. This sample size achieves 90% power to detect a difference of 14.6% between the two groups survival using a one-sided binomial test. This trial is designed to confirm the effectiveness of Simvastatin to protect healthy and steatotic livers undergoing cold storage and warm reperfusion before transplantation and to evaluate if the addition of Simvastatin translates into improved graft outcomes. ISRCTN27083228 .